Compare Abbott Laboratories (ABT) vs Comfort Systems USA Inc (FIX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Comfort Systems USA Inc — how do they compare? Abbott Laboratories trades at $95.69 (market cap $166.94B), while Comfort Systems USA Inc trades at $1,655.81 (market cap $59.26B). The key difference: Abbott Laboratories is far larger — about 2.8× Comfort Systems USA Inc's market cap, and Abbott Laboratories pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| ABT | FIX | |
|---|---|---|
Market Cap | $166.94B | $59.26B |
Sector | Health | Technology |
52-Week High | $136.62 | $2.07K |
52-Week Low | $82.57 | $527.42 |
Enterprise Value | $193.69B | $58.55B |
Dividend Yield | 2.63% | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Comfort Systems USA (FIX) trades at $1,793.03, up 2.97% with strong earnings momentum as Q1 2026 EPS of $10.51 beat expectations of $6.81. The stock shows bearish technical signals but maintains robust fundamentals with 2025 revenue of $9.10B and net income of $1.02B. Recent news highlights leadership transitions and data center cooling demand driving growth.
Outlook remains positive with analyst consensus price target of $2,080 representing 16% upside potential. Key risks include execution challenges from record backlog and competitive pressures in HVAC infrastructure. The company's strong cash flow generation supports dividend payments and strategic acquisitions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Comfort Systems USA Inc
Comfort Systems USA is a premier provider of mechanical and electrical contracting services. It specializes in HVAC, plumbing, and energy management solutions for commercial and industrial facilities.
Read more on FIX →
